Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Issue Archive

Table of Contents

EXCEPTIONAL CASE REPORTS

CLINICAL TRIALS AND OBSERVATIONS

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

TRANSFUSION MEDICINE

Tamir Kanias,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Marion C. Lanteri,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Grier P. Page,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Yuelong Guo,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Stacy M. Endres,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Mars Stone,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Sheila Keating,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Alan E. Mast,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Ritchard G. Cable,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Darrell J. Triulzi,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Joseph E. Kiss,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Edward L. Murphy,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Steve Kleinman,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Michael P. Busch,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program,Mark T. Gladwin,for the National Heart, Lung, and Blood Institute Recipient Epidemiology Donor Evaluation Study III (REDS-III) Program

TRANSPLANTATION

Jaime Sanz,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Mi Kwon,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Guiomar Bautista,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Miguel A. Sanz,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Pascual Balsalobre,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),José Luis Piñana,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Carlos Solano,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Rafael Duarte,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Christelle Ferrá,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Ignacio Lorenzo,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Carmen Martín,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Pere Barba,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),María Jesús Pascual,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Rodrigo Martino,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Jorge Gayoso,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Ismael Buño,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Carmen Regidor,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Almudena de la Iglesia,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Juan Montoro,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),José Luis Díez-Martín,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Guillermo F. Sanz,on behalf of Grupo Español de Trasplante Hematopoyético (GETH),Rafael Cabrera,on behalf of Grupo Español de Trasplante Hematopoyético (GETH)

COMMENTARIES

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals